Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
about
BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repressionMultimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the LiteratureFunctions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiationChildren's Oncology Group's 2013 blueprint for research: bone tumorsCharacterization and drug resistance patterns of Ewing's sarcoma family tumor cell linesCD133 expression in chemo-resistant Ewing sarcoma cellsThe genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma developmentRedirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Ewing's Sarcoma and Second MalignanciesCell Cycle Deregulation in Ewing's Sarcoma PathogenesisEwing tumor: tumor biology and clinical applications.Biology of EWS/ETS fusions in Ewing's family tumors.Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence.Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.Copy Number Alterations and Methylation in Ewing's Sarcoma.Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromasAssociation of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.Recent advances in the molecular pathogenesis of Ewing's sarcoma.Prognostic impact of chromosomal aberrations in Ewing tumoursTissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell linesBiomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcomaA molecular function map of Ewing's sarcoma.Molecular abnormalities in Ewing's sarcoma.Advances in the identification of molecular markers for bone neoplasia.The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.Progress in the molecular biology of ewing tumors.Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma.Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.Response of Ewing tumor cells to forced and activated p53 expression.Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type.Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.
P2860
Q54871661-8DAB6601-FA56-4A04-8528-7C08ABDF847FQ54900239-5CC1B3E8-C002-40D7-8178-F98AFFCF03D0Q54952083-F439D196-6131-412C-8572-82F8CEF383E6Q54952084-51971C11-881E-4A6E-A4E0-65AA99C79753Q54955761-F33A5F5C-5F30-42FB-A52D-9D56E125B03AQ54955763-447E8423-B0F8-4C9C-ABDB-9BE8DC52CA2EQ54955764-7C24DD7D-881C-4420-BE2D-69CDF2995BD1Q54955769-8D72CDCE-017F-4039-9655-DC0AA66EC4BCQ54955771-20E60956-E197-49CC-8C48-2457950E5F1CQ54955772-D0F2C408-5C7D-4426-BACA-614FC818A6E6Q54955773-BAB8F73A-DAFB-4127-BAAA-64A647F6BDDEQ54955776-627832DB-ED1E-4F18-973D-C7BE68CF8804Q54955777-B31F1BC3-1779-4722-8E81-22A04C33CBB7Q54955778-5BED50AD-CC79-426C-B762-351ED9BDBE07Q54955780-A93BF0DB-B082-4EFE-A4CF-1A17E77E3799Q54955781-181AD26E-07AC-4F93-BF2E-1061F1E306B6Q54955783-EA9320CF-6F09-4588-ABA2-07DA7A73EC72
P1343
Q24650619-3A3C36C8-1B60-491D-96F0-B8D238C42402Q26740437-D84E215A-0645-4670-A136-B3A9903363E0Q26849397-E3C5B70E-AE46-4DBB-9EC6-BB2B2F00C7CDQ27027664-4EEC3287-99BB-4D11-8CCC-3BD6E0EC5E4EQ28535586-3362F316-A4C1-430B-A7D0-F6688B5C0983Q33546702-5BC621E9-BE0D-43F2-9A8F-E5F0CADB2D2EQ33881163-76460B7A-4BF0-4B6B-A0C1-6276A60F1CF4Q33997274-E7D7951B-B27C-4547-A0E5-146EE45433B2Q34166288-A4DA025D-AACD-40BF-838A-624C17C450D3Q34215135-37601264-FCCE-4FA9-9BF6-90179143ED44Q34260723-383E8EC7-42EE-4DB0-B865-DCE68BC2CADCQ34317033-DB78DD03-628E-49F7-B354-1FC28C2EBB35Q34405501-9B6CCF7F-BEA1-4DC2-AE59-D796260EF820Q34460916-3C130F66-16C4-4F28-9A6E-B4A977CE17B0Q34492346-0B88062C-3245-450E-B517-F81D731327BCQ34666892-B3965993-38E4-4D16-9C1E-C8C5EF75930FQ34691553-9B2444B7-7901-4A1D-91D3-39F98900BD82Q34700651-CCF18B45-5D30-43EE-B2DB-C0918C634164Q35057457-B0F197F7-6BBD-49CA-876E-4BB498E8DB6EQ35788019-AA224C69-9CF9-496F-A86B-3D687D3E3CF8Q35809865-4394D356-1D9A-44BE-AAA1-C9463A744152Q36562720-D5FA5F3E-1D6F-4A8F-9F82-08FB61983386Q36644524-1B3C942C-2CC7-43D7-ABB3-4183E0AC4821Q36817845-3CD6D35D-9B47-4EEF-BBC3-DA5627218B93Q36907188-D9666FA3-190F-4C9D-A04A-FB3B3BA0F17BQ37135628-746FCE25-8FA2-4887-9F18-8D43C2DBCE72Q37165799-984760D0-7830-4FAB-8E2A-82259F02E09BQ37300040-6BF0F4F6-98E5-4CCD-9C9C-B2903FEE8BB7Q38089888-9C956F37-0CED-4730-ABB2-D48863792587Q38289575-289A33F7-879F-473C-9A9A-B15FC52F0D0EQ38303169-03815D7B-260B-4D67-A74E-9E13521C55DDQ38612055-5997C578-F9A0-44FB-89FA-1350CB11F88FQ39113281-596C9AD1-C55A-4473-A0F7-A88FAF14CB1BQ39634845-455FE00F-F966-432B-9941-79DD06C2D039Q40030553-49FFE72B-8262-4311-9B45-20962FF8341BQ40126904-71ADE12F-3A94-46C6-9202-1B7B45BD506CQ40645830-1C7E3966-B685-49AE-8E11-B901FEBEC945Q40834415-C1AD91D2-EF4D-40AE-8C40-A57A9DF50530Q42820932-BA41FD20-503C-4E86-9648-4BEB775712D1Q44185433-628A23F3-1F98-45F7-915D-8A74382ED289
P2860
Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Among genes involved in the RB ...... in the Ewing family of tumors.
@en
Among genes involved in the RB ...... in the Ewing family of tumors.
@nl
type
label
Among genes involved in the RB ...... in the Ewing family of tumors.
@en
Among genes involved in the RB ...... in the Ewing family of tumors.
@nl
prefLabel
Among genes involved in the RB ...... in the Ewing family of tumors.
@en
Among genes involved in the RB ...... in the Ewing family of tumors.
@nl
P2093
P4510
P50
P356
P1433
P1476
Among genes involved in the RB ...... in the Ewing family of tumors
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1201397
P407
P577
1997-10-01T00:00:00Z
P5875
P6179
1004676244